Nelson Advisors has spent 2026 doing two things at once: closing lower-mid-market healthtech deals and telling the rest of the market what it sees. The London-based firm, co-founded by partners Lloyd Price and Paul Hemings, specialises in mergers, acquisitions, partnerships and investments for HealthTech, MedTech, Digital Health, Health IT and Health AI companies with enterprise values between roughly $25 million and $250 million.

KPMG’s 2026 healthcare technology report, based on interviews with 128 senior healthcare technology executives at organisations with revenues above US$1 Billion, finds a sector investing heavily in digital transformation but still struggling to convert that spend into measurable value. KPMG describes organisations as sitting in one of three modes: stabilising core platforms and data integrity, synchronising systems and governance, or scaling AI across workflows at enterprise

Nelson Advisors: Heidi Health, Best Practice and the challenge facing clinical AI is not accuracy of ML models, but access to data infrastructure and integration permissions within established systems. The primary care health technology landscape is undergoing a structural transition from assistive ambient transcription utilities to autonomous, agentic artificial intelligence systems. For several years, ambient voice technology (AVT) operated as a non-invasive layer at the cl